Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-23-003321
Filing Date
2023-10-13
Accepted
2023-10-13 08:13:58
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 zk2330369.htm F-3 381403
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 8119
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 10594
4 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4164
5 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 41327
6 image1.jpg GRAPHIC 1091
7 image2.jpg GRAPHIC 2251
8 image3.jpg GRAPHIC 1155
9 image00004.jpg GRAPHIC 62448
10 image00005.jpg GRAPHIC 106520
11 image00009.jpg GRAPHIC 4065
12 image00010.jpg GRAPHIC 13924
  Complete submission text file 0001178913-23-003321.txt   710879
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: F-3 | Act: 33 | File No.: 333-274957 | Film No.: 231323955
SIC: 2834 Pharmaceutical Preparations